FDA Approves DATSCAN — Medi-Physics Inc. dba GE Healthcare.

# FDA Approves GE Healthcare's DaTscan for Parkinson's Disease Diagnosis GE Healthcare's Medi-Physics division received FDA approval for DaTscan (ioflupane I-123), a diagnostic imaging agent that enables clinicians to visualize dopamine activity in the brain, potentially strengthening the company's position in the neurodegenerative disease diagnostics market. The intravenous agent addresses an unmet clinical need in Parkinson's disease diagnosis, offering GE Healthcare an opportunity to expand its molecular imaging portfolio and capture market share in the growing neuroimaging sector